FibroSIGHT™ Plus: Precision in Fibrosis Assessment with AI-based Analysis

qFibrosis enables earlier detection of fibrosis response in Efruxifermin-treated patients with F2-F3 MASH in 96-week HARMONY study

-TOP_458_EASL2025